Antioxidant ebselen reduces oxidative damage in focal cerebral ischemia

Free Radical Biology and Medicine

Volumn 34, Issue 1, 2003, Pages 56-63

  Imai, Hideaki ^a   Graham, David Ian ^a   Masayasu, Hiroyuki ^b   Macrae, Iseabail Mhairi ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

4 Hydroxynonenal; 8 Hydroxy 2 deoxyguanosine; Ebselen; Free radical damage; Lipid peroxidation; Oxidative stress; Rat; Stroke

Indexed keywords

4 HYDROXYNONENAL; ANTIBODY; ANTIOXIDANT; DEOXYGUANOSINE; DNA; EBSELEN; FREE RADICAL; HISTIDINE; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN REGION; CONTROLLED STUDY; DNA DAMAGE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; HISTOPATHOLOGY; HYDROXYLATION; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STROKE; TOPOGRAPHY;

ANIMALS; ANTIOXIDANTS; AZOLES; BRAIN ISCHEMIA; IMMUNOHISTOCHEMISTRY; MALE; ORGANOSELENIUM COMPOUNDS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037218577     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01180-2     Document Type: Article

References (44)

1. Tamura A., Graham D.I., McCulloch J., Teasdale G.M. Focal ischemia in the rat. 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1:1981;3-60.
2. Astrup J., Siesjo B.K., Symon L. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke. 12:1981;723-725.
3. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke an integrated view. Trends Neurosci. 22:1999;391-397.
4. Chan P.H. Role of oxidants in ischemic brain damage. Stroke. 27:1996;1124-1129.
5. Cui J., Holmes E.H., Greene T.G., Liu P.K. Oxidative DNA damage precedes DNA fragmentation after experimental stroke in rat brain. FASEB J. 14:2000;955-967.
6. Muller A., Cadenas E., Graf P., Sies H. A novel biologically active seleno-organic compound-I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen). Biochem Pharmacol. 33:1984;3235-3239.
7. Maiorino M., Roveri A., Coassin M., Ursini F. Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51). Biochem Pharmacol. 37:1988;2267-2271.
8. Zhao R., Masayasu H., Holmgren A. Ebselen a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc. Natl. Acad. Sci. USA. 99:2002;8579-8584.
9. Dawson D.A., Masayasu H., Graham D.I., Macrae I.M. The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischemia in the rat. Neurosci Lett. 185:1995;65-69.
10. Takasago T., Peters E.E., Graham D.I., Macrae I.M. Neuroprotective efficacy of ebselen, an antioxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion. Br J Pharmacol. 122:1997;1251-1256.
11. Yamaguchi T., Sano K., Takakura K., Saito I., Shinohara Y., Asano T. Yasuhara H. Ebselen in acute ischemic stroke a placebo-controlled, double-blind clinical trial. Stroke. 29:1998;12-17.
12. Ogawa A., Yoshimoto T., Kikuchi H., Sano K., Saito I., Yamaguchi T., Yasuhara H. Ebselen in acute middle cerebral artery occlusion a placebo-controlled, double-blind clinical trial. Cerebrovasc Dis. 9:1999;112-118.
13. Culp S.J., Cho B.P., Kadlubar F.F., Evans F.F. Structural and conformational analyses of 8-hydroxy-2′-deoxyguanosine. Chem Res Toxicol. 2:1989;416-422.
14. 15N Nuclear magnetic resonance studies on the tautomerism of 8-hydroxy-2′-deoxyguanosine, 8-hydroxyguanosine, and other C8-substituted guanine nucleosides. Chem Res Toxicol. 3:1990;445-452.
15. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 11:1991;81-128.
16. Halliwell B. Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species measurement, mechanism and the effects of nutrition. Mutat Res. 443:1999;37-52.
17. Toyokuni S., Tanaka T., Hattori Y., Nishiyama Y., Yoshida A., Uchida K., Hiai H., Ochi H., Osawa T. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1 its application toferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest. 76:1997;365-374.
18. Tanaka T., Nishiyama Y., Okada K., Hirota K., Matsui M., Yodoi J., Hiai H., Toyokuni S. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney independence of tubular necrosis and sulfhydryl depletion. Lab Invest. 77:1997;145-155.
19. Toyokuni S., Miyake N., Hiai H., Hagiwara M., Kawakishi S., Osawa T., Uchida K. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett. 359:1995;189-191.
20. Keyser J.D., Sulter G., Luiten P.G. Clinical trials with neuroprotective drugs in acute ischaemic stroke are we doing the right thing? Trends Neurosci. 22:1999;535-540.
21. Poli G., Schaur R.J. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life. 50:2000;315-321.
22. Burcham P.C. Genotoxic lipid peroxidation products their DNA damaging properties and role in formation of endogenous DNA adducts. Mutagenesis. 13:1998;287-305.
23. McCracken E., Valeriani V., Simpson C., Jover T., McCulloch J., Dewar D. The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes. J Cereb Blood Flow Metab. 20:2000;1529-1536.
24. Termini J. Hydroperoxide-induced DNA damage and mutations. Mutat Res. 450:2000;107-124.
25. Masuda M., Suzuki T., Frieesen M.D., Ravanat J.-L., Cadet J., Pignatelli B., Nishino H., Ohshima H. Chlorination of guanosine and other nucleosides by hypochlorous acid and myeloperoxide of activated human neutrophils. J Biol Chem. 276:2001;40486-40496.
26. Liu P.K., Hsu C.Y., Dizdaroglu M., Floyd R.A., Kow Y.W., Karakaya A., Rabow L.E., Cui J.-K. Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion. J Neurosci. 16:1996;6795-6806.
27. Hayashi T., Sakurai M., Itoyama Y., Abe K. Oxidative damage and breakage of DNA in rat brain after transient MCA occlusion. Brain Res. 832:1999;159-163.
28. Zhang, J.; Dawson, V. L.; Dawson, T. M.; Snyder, S. H. Nitric oxide activation of poly(ADP-ribose)synthase in neurotoxicity. Science 263:687-689.
29. Clark J.S., Carswell H.V.O., Cervantes D.N., Brain N.J.R., Brosnan M.J., Carr F.J., Van Vooren P., Szpirer C., Macrae I.M., Dominiczak A.F. Manganese superoxide dismutase (SOD-2) as a candidate gene for hypertension and stroke in the stroke prone spontaneously hypertensive rat (SHRSP). J Hypertens. 18:(Suppl. 4):2000;S171.
30. Toyoda T., Lee K.S. Differential induction of superoxide dismutase in core and penumbra regions after transient focal ischemia in the rat neocortex. Neurosci Lett. 235:1997;29-32.
31. Mahadik S.P., Makar T.K., Murthy J.N., Ortiz A., Wakade C.G., Karpiak S.E. Temporal changes in superoxide dismutase, glutathione peroxidase and catalase levels in primary and peri-ischemic tissue. Monosialoganglioside (GM1) treatment effects. Mol Chem Neuropathol. 18:1993;1-14.
32. Sermet A., Tasdemir N., Deniz B., Atmaca M. Time-dependent changes in superoxide dismutase, catalase, xanthine dehydrogenase and oxidase activities in focal cerebral ischaemia. Cytobios. 102:2000;157-172.
33. Ohtsuki T., Matsumoto M., Hayashi Y., Yamamoto K., Kitagawa K., Ogawa S., Yamamoto S., Kamada T. Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am J Physiol. 268:1995;H1249-H1257.
34. Schwab J.M., Nguyen T.D., Postler E., Meyermann R., Schluesener H.J. Selective accumulation of cyclooxygenases-1-expressing microglial cells/macrophages in lesions of human focal cerebral ischemia. Acta Neuropathol. (Berl.). 99:2000;609-614.
35. Walder C.E., Green S.P., Darbonne W.C., Mathias J., Rae J., Dinauer M.C., Curnutte J.T., Thomas G.R. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke. 28:1997;2252-2258.
36. Becker L.B., van den Hoek T.L., Shao Z.H., Li C.Q., Schumacker P.T. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol. 277:1999;H2240-H2246.
37. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. 1999;Oxford University Press, Oxford, UK.
38. Turrens J.F., Beconi M., Barilla J., Chavez U.B., McCord J.M. Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues. Free Radic Res Commun. 12-13:1991;681-689.
39. Hattori R., Inoue R., Sase K., Eizawa H., Kosuga K., Aoyama T., Masayasu H., Kawai C., Sasayama S., Yui Y. Preferential inhibition of inducible nitric oxide synthase by ebselen. Eur J Pharmacol. 267:1994;R1-R2.
40. Schewe C., Schewe T., Wendel A. Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione. Biochem Pharmacol. 48:1994;65-74.
41. Cotgreave I.A., Duddy S.K., Kass G.E., Thompson D., Moldeus P. Studies on the anti-inflammatory activity of ebselen. Ebselen interferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C? Biochem Pharmacol. 38:1989;649-656.
42. Bindoli A. Lipid peroxidation in mitochondria. Free Radic Biol Med. 5:1988;247-261.
43. Boireau A., Dubedat P., Bordier F., Coimbra M., Meunier M., Imperato A., Moussaoui S. Effects of ebselen, a glutathione peroxidase mimic, in several models of mitochondrial dysfunction. Ann N Y Acad Sci. 893:1999;254-257.
44. Malecki A., Garrido R., Mattson M.P., Hennig B., Toborek M. 4-Hydroxynonenal induces oxidative stress and death of cultured spinal cord neurons. J Neurochem. 74:2000;2278-2287.